You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 11, November 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Desmoid Tumor

IV. Choice of Treatment, Results, and Complications

Jyrki J. Reitamo, MD

Arch Surg. 1983;118(11):1318-1322.


Abstract

• We analyzed the results of treatment in 89 cases of desmoid tumor (DT) with a follow-up period of 9.3±5.9 years. After surgical removal, the frequency of recurrence was equal, regardless of whether a complete removal of the tumor was obtained or not. After combined operation and radiotherapy, recurrence was higher. A higher frequency of recurrences was observed in extraabdominal (45%) v abdominal (10%) DTs. Recurrence was particularly high in the juvenile variety (70%), and low in the DTs of fertile women (11%). If a recurrence followed the first operation, multiple recurrences were the rule. Spontaneous regression was observed in 4% of the cases. The results emphasize that the basic biologic characteristics of this rare neoplasm have a greater impact on the results than the operation itself. A simple excision at the primary operation is recommended.

(Arch Surg 1983;118:1318-1322)



Author Affiliations

From the Transplantation Laboratory and Fourth Department of Surgery, University of Helsinki.


Footnotes

Accepted for publication April 29, 1983.

Deceased.

Reprint requests to Transplantation Laboratory, University of Helsinki, Haartmaninkatu 3, SF 00290, Helsinki 29, Finland (Pekka Häyry, MD).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Successful Chemotherapeutic Modality of Doxorubicin Plus Dacarbazine for the Treatment of Desmoid Tumors in Association With Familial Adenomatous Polyposis
Gega et al.
JCO 2006;24:102-105.
ABSTRACT | FULL TEXT  

Desmoid Tumor: Prognostic Factors and Outcome After Surgery, Radiation Therapy, or Combined Surgery and Radiation Therapy
Ballo et al.
JCO 1999;17:158-158.
ABSTRACT | FULL TEXT  

Desmoid Tumor (Fibromatosis) of the Breast: A Clinician's Dilemma--A Case Report and Review
Ng et al.
Arch Surg 1997;132:444-446.
ABSTRACT  

ß-Radiation to Reduce Restenosis: Too Little, Too Soon?
Teirstein
Circulation 1997;95:1095-1097.
FULL TEXT  

The Desmoid Tumor: Not a Benign Disease
Posner et al.
Arch Surg 1989;124:191-196.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.